MiMedx Group, Inc. Loss Contingency Accrual, Period Increase (Decrease)
MiMedx Group, Inc. (MDXG) had Loss Contingency Accrual, Period Increase (Decrease) of -$2.40 million as of 2021-04-15, per its 10-Q filed 2021-08-03.
Discontinued › Notes › Commitment and Contingencies › Loss Contingency › Loss Contingency Accrual, Disclosures
us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease · last filed 2021-08-03
- 2021-04-15: Loss Contingency Accrual, Period Increase (Decrease) -$2.40M.
| Period end | Loss Contingency Accrual, Period Increase (Decrease) |
|---|---|
| 2021-04-15 | -$2.40M 10-Q · filed 2021-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |